Literature DB >> 14648133

Connective tissue growth factor in tear film of the horse: detection, identification and origin.

F J Ollivier1, D E Brooks2, G S Schultz3, T D Blalock3, S E Andrew1, A M Komaromy1, T J Cutler1, M E Lassaline1, M E Kallberg1, G B Van Setten4.   

Abstract

BACKGROUND: Healing of corneal ulcers in horses is often associated with profound corneal stromal fibrosis and scar formation resulting in visual impairment. Connective tissue growth factor (CTGF) is a fibrogenic cytokine involved in wound healing and scarring. The purpose of this study was to determine whether CTGF was present in the tear fluid of normal horse eyes and the eyes of horses with corneal ulcers in order to evaluate the role of CTGF in corneal wound healing and corneal scar formation.
METHODS: Tear fluid samples were collected from 65 eyes of 44 horses; 32 samples from normal eyes, 21 samples from eyes with corneal ulceration, and 12 samples from the unaffected contralateral eyes of horses with ulcers. CTGF levels in the tears were determined by enzyme immunoassay using goat IgG against human CTGF. Antigenetic similarity of human and horse CTGF was established in a bio-equivalence assay. The identity of horse CTGF was confirmed by western blot. Lacrimal and nictitating membrane glands were investigated by immunohistochemistry in the attempt to clarify the origin of tear fluid CTGF.
RESULTS: CTGF was detected in tear film of 23 normal unaffected eyes (72%) and 8 normal contralateral eyes (67%), with the mean CTGF levels (+/- SEM) being 51.5+/-19.2 and 13.4+/-3.9 ng/ml respectively. CTGF was found in 8 eyes with corneal ulcers (38%) with the mean CTGF concentration of 26.3+/-14.8 ng/ml. Western blot identified the protein detected as CTGF. The identification of CTGF in lacrimal glands suggests a major role of these glands in the presence of CTGF in tears.
CONCLUSIONS: CTGF is present in horse tear fluid and derives, at least partly, from the lacrimal gland. Equine CTGF has strong antigenic similarity with human CTGF. Corneal disease leads to a decrease of CTGF concentrations in tears. The possible role of CTGF in the healing process of ocular surface requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648133     DOI: 10.1007/s00417-003-0802-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  31 in total

Review 1.  Regulation of proteolytic activity in tissues.

Authors:  S S Twining
Journal:  Crit Rev Biochem Mol Biol       Date:  1994       Impact factor: 8.250

2.  Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

Authors:  S Sato; T Nagaoka; M Hasegawa; T Tamatani; T Nakanishi; M Takigawa; K Takehara
Journal:  J Rheumatol       Date:  2000-01       Impact factor: 4.666

3.  Characterization of human corneal collagenase.

Authors:  M B Berman; A P Kerza-Kwiatecki; P F Davison
Journal:  Exp Eye Res       Date:  1973-03       Impact factor: 3.467

4.  Proteinase inhibitor in human tears.

Authors:  F Kueppers
Journal:  Biochim Biophys Acta       Date:  1971-03-23

5.  Protease activities in human tears.

Authors:  P K Tsung; F J Holly
Journal:  Curr Eye Res       Date:  1981       Impact factor: 2.424

Review 6.  Growth regulation of skin fibroblasts.

Authors:  K Takehara
Journal:  J Dermatol Sci       Date:  2000-12       Impact factor: 4.563

7.  CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis.

Authors:  M M Chen; A Lam; J A Abraham; G F Schreiner; A H Joly
Journal:  J Mol Cell Cardiol       Date:  2000-10       Impact factor: 5.000

Review 8.  Epidermal growth factor (EGF) in ocular fluids: presence, origin and therapeutical considerations.

Authors:  G B van Setten; T Tervo; K Tervo; A Tarkkanen
Journal:  Acta Ophthalmol Suppl       Date:  1992

9.  Alpha 2-macroglobulin is present in and synthesized by the cornea.

Authors:  S S Twining; T Fukuchi; B Y Yue; P M Wilson; X Zhou; G Loushin
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-07       Impact factor: 4.799

10.  Elevation of tear fluid plasmin in corneal disease.

Authors:  T Tervo; E M Salonen; A Vahen; I Immonen; G B van Setten; J J Himberg; A Tarkkanen
Journal:  Acta Ophthalmol (Copenh)       Date:  1988-08
View more
  1 in total

1.  Investigation of the human tear film proteome using multiple proteomic approaches.

Authors:  Kari B Green-Church; Kelly K Nichols; Nan M Kleinholz; Liwen Zhang; Jason J Nichols
Journal:  Mol Vis       Date:  2008-03-07       Impact factor: 2.367

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.